Results of Bile and Blood Culture in Patients With Acute Cholangitis
A Comparison of Results With Bile and Blood Culture in Patients With Acute Cholangitis According to Severity
Sponsor: Seoul National University Hospital
Terminated
Because of small number of enrolled patients, we terminated this study.
Other terminated trials from Seoul National University Hospital
- Intrahepatic Cholangiocarcinoma (Icc) · Jul 2025
- Peripheral T-cell Lymphoma (PTCL) · Phase PHASE2 · Dec 2024
- Central Nervous System Lymphoma · Phase PHASE2 · Sep 2024
- Rectal Cancer, Adenocarcinoma · Phase NA · Aug 2024
- Variant Angina · Jun 2024
See all terminations from Seoul National University Hospital
This observational or N/A phase trial investigates Cholangitis and is currently terminated or withdrawn. Seoul National University Hospital leads this study, which shows 7 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Terminated
-
Sep 2024 — Sep 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Terminated NA
First recorded
Apr 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Seoul National University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .